Apolipoprotein B for the refinement of cardiovascular risk assessment - Top-Institutions - MDSpire

Apolipoprotein B for the refinement of cardiovascular risk assessment

  • By

  • Julius L Katzmann

  • Ulrich Laufs

  • January 21, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Lipidology
    • Epidemiology

  • #2

    Harvard Medical School / Brigham and Women's Hospital
    Harvard Medical School / Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Lipidology
    • Preventive Medicine

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Lipidology
    • Molecular Medicine

  • #4

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Lipidology
    • Clinical Research

  • #5

    Imperial College London
    Imperial College London

    London, N/A

    Key Differentiators

    • Cardiology
    • Lipidology
    • Population Health

Original Source(s)

Apolipoprotein B for the refinement of cardiovascular risk assessment

  • by Julius L Katzmann, Ulrich Laufs

  • January 21, 2026

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes

What RVO May Reveal About Systemic Health

TriNetX data presented at Retina World Congress linked BRVO and CRVO with increased risks of stroke, myocardial infarction, and carotid disease.